ARS Pharmaceuticals (SPRY) FCF Margin (2022 - 2026)
ARS Pharmaceuticals (SPRY) recorded FCF Margin of -181.02% in Q2 2026, up 71.21 percentage points from -252.23% a year earlier and up 17.15 percentage points from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) FCF Margin (2022 - 2026) Analysis & Trends
On a TTM basis, ARS Pharmaceuticals' FCF Margin came in at -168.14% as of Jun 30, 2026, down 120.62 percentage points year-over-year; for FY2025, it came in at -203.14%, down 217.71 percentage points from FY2024.
- Annual FCF Margin has a four-year change of +116.80 percentage points (FY2021 to FY2025).
- Across earlier years, FCF Margin came in at 14.57% in FY2024 (+198151.23 pp), -198136.67% in FY2023 (-195076.10 pp), -3060.56% in FY2022 (-2740.62 pp) and -319.94% in FY2021.
- Quarterly FCF Margin has ranged from -166990.00% in Q2 2023 to 48.17% in Q4 2024 over the past five years.
- On a year-over-year basis, FCF Margin rose in four of the last five quarters, with an average year-over-year change of +390.87 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 165526.60 percentage points in Q2 2024, against a drop of 165482.24 percentage points in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -198.17% (Q1 2026), -154.82% (Q4 2025) and -145.36% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | ARS Pharmaceuticals | 410.68 Mn | 266.88 Mn | 20.81 Mn | -181.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -181.02% |
| Mar 31, 2026 | -198.17% |
| Dec 31, 2025 | -154.82% |
| Sep 30, 2025 | -145.36% |
| Jun 30, 2025 | -252.23% |
| Mar 31, 2025 | -512.14% |
| Dec 31, 2024 | 48.17% |
| Sep 30, 2024 | -706.33% |
| Jun 30, 2024 | -1,463.40% |
| Jun 30, 2023 | -166,990.00% |
| Mar 31, 2023 | -63,110.00% |
| Sep 30, 2022 | -3,022.22% |
| Jun 30, 2022 | -1,507.76% |
| Mar 31, 2022 | -1,047.66% |
API Access
ARS Pharmaceuticals FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();